HPV Vaccination Among Young Adults in the US

The human papillomavirus (HPV) vaccine was approved for females in 2006 and males in 2009 for the prevention of anogenital cancer and warts. The indications were expanded in 2020 to include the prevention of oropharyngeal cancer, which is more common in males. The Advisory Committee on Immunization...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA : the journal of the American Medical Association 2021-04, Vol.325 (16), p.1673-1674
Hauptverfasser: Chen, Michelle M, Mott, Nicole, Clark, Sarah J, Harper, Diane M, Shuman, Andrew G, Prince, Mark E. P, Dossett, Lesly A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1674
container_issue 16
container_start_page 1673
container_title JAMA : the journal of the American Medical Association
container_volume 325
creator Chen, Michelle M
Mott, Nicole
Clark, Sarah J
Harper, Diane M
Shuman, Andrew G
Prince, Mark E. P
Dossett, Lesly A
description The human papillomavirus (HPV) vaccine was approved for females in 2006 and males in 2009 for the prevention of anogenital cancer and warts. The indications were expanded in 2020 to include the prevention of oropharyngeal cancer, which is more common in males. The Advisory Committee on Immunization Practices recommends routine vaccination with 2 doses at age 11 to 12 years, with catch-up vaccination at age 13 to 26 years (limited to age 13-21 years from 2011 to 2019 for males).2 If the first dose occurs after age 15 years, a 3-dose series is recommended.
doi_str_mv 10.1001/jama.2021.0725
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8080227</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>2779209</ama_id><sourcerecordid>2531349157</sourcerecordid><originalsourceid>FETCH-LOGICAL-a503t-469d8b4074af11fe7a441eb2540a0e9fa6add6eec5b7da86cf01972280b252513</originalsourceid><addsrcrecordid>eNpdkc9LwzAUx4Mobk6vHjxIwYsHW19-dEkuwhjqhIGCbuApZG26dbSNNq3gf2_KfqDmkBy-n_d97-WL0DmGCAPg27UudUSA4Ag4iQ9QH8dUhDSW4hD1AaQIOROsh06cW4M_mPJj1KNUAhNc9NHN5GUezHWS5JVuclsFo9JWy-Ddtv4epW3RuCCvgmZlgtnrKTrKdOHM2fYdoNnD_dt4Ek6fH5_Go2moY6BNyIYyFQsGnOkM48xwzRg2CxIz0GBkpoc6TYfGJPGCp1oMkwyw5IQI8AyJMR2gu43vR7soTZqYqql1oT7qvNT1t7I6V3-VKl-ppf1SAgQQwr3B9dagtp-tcY0qc5eYotCVsa1TvomQgnJgHr36h65tW1d-PU9RTJnEcWcYbaikts7VJtsPg0F1QaguCNUFobogfMHl7xX2-O7nPXCxAbq6nUo4lwQk_QEvv4qr</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2531349157</pqid></control><display><type>article</type><title>HPV Vaccination Among Young Adults in the US</title><source>MEDLINE</source><source>American Medical Association Journals</source><creator>Chen, Michelle M ; Mott, Nicole ; Clark, Sarah J ; Harper, Diane M ; Shuman, Andrew G ; Prince, Mark E. P ; Dossett, Lesly A</creator><creatorcontrib>Chen, Michelle M ; Mott, Nicole ; Clark, Sarah J ; Harper, Diane M ; Shuman, Andrew G ; Prince, Mark E. P ; Dossett, Lesly A</creatorcontrib><description>The human papillomavirus (HPV) vaccine was approved for females in 2006 and males in 2009 for the prevention of anogenital cancer and warts. The indications were expanded in 2020 to include the prevention of oropharyngeal cancer, which is more common in males. The Advisory Committee on Immunization Practices recommends routine vaccination with 2 doses at age 11 to 12 years, with catch-up vaccination at age 13 to 26 years (limited to age 13-21 years from 2011 to 2019 for males).2 If the first dose occurs after age 15 years, a 3-dose series is recommended.</description><identifier>ISSN: 0098-7484</identifier><identifier>EISSN: 1538-3598</identifier><identifier>DOI: 10.1001/jama.2021.0725</identifier><identifier>PMID: 33904878</identifier><language>eng</language><publisher>United States: American Medical Association</publisher><subject>Adolescent ; Age ; Anogenital ; Cancer ; Female ; Human papillomavirus ; Humans ; Immunization ; Letter ; Letters ; Male ; Males ; Oropharyngeal cancer ; Papillomavirus Infections - prevention &amp; control ; Papillomavirus Vaccines ; Patient Acceptance of Health Care - statistics &amp; numerical data ; Prevention ; Research Letter ; United States ; Vaccination ; Vaccination - statistics &amp; numerical data ; Vaccination - trends ; Vaccines ; Warts ; Young Adult ; Young adults</subject><ispartof>JAMA : the journal of the American Medical Association, 2021-04, Vol.325 (16), p.1673-1674</ispartof><rights>Copyright American Medical Association Apr 27, 2021</rights><rights>Copyright 2021 American Medical Association. All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a503t-469d8b4074af11fe7a441eb2540a0e9fa6add6eec5b7da86cf01972280b252513</citedby><cites>FETCH-LOGICAL-a503t-469d8b4074af11fe7a441eb2540a0e9fa6add6eec5b7da86cf01972280b252513</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jama/articlepdf/10.1001/jama.2021.0725$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.0725$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,230,314,780,784,885,3340,27924,27925,76489,76492</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33904878$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Michelle M</creatorcontrib><creatorcontrib>Mott, Nicole</creatorcontrib><creatorcontrib>Clark, Sarah J</creatorcontrib><creatorcontrib>Harper, Diane M</creatorcontrib><creatorcontrib>Shuman, Andrew G</creatorcontrib><creatorcontrib>Prince, Mark E. P</creatorcontrib><creatorcontrib>Dossett, Lesly A</creatorcontrib><title>HPV Vaccination Among Young Adults in the US</title><title>JAMA : the journal of the American Medical Association</title><addtitle>JAMA</addtitle><description>The human papillomavirus (HPV) vaccine was approved for females in 2006 and males in 2009 for the prevention of anogenital cancer and warts. The indications were expanded in 2020 to include the prevention of oropharyngeal cancer, which is more common in males. The Advisory Committee on Immunization Practices recommends routine vaccination with 2 doses at age 11 to 12 years, with catch-up vaccination at age 13 to 26 years (limited to age 13-21 years from 2011 to 2019 for males).2 If the first dose occurs after age 15 years, a 3-dose series is recommended.</description><subject>Adolescent</subject><subject>Age</subject><subject>Anogenital</subject><subject>Cancer</subject><subject>Female</subject><subject>Human papillomavirus</subject><subject>Humans</subject><subject>Immunization</subject><subject>Letter</subject><subject>Letters</subject><subject>Male</subject><subject>Males</subject><subject>Oropharyngeal cancer</subject><subject>Papillomavirus Infections - prevention &amp; control</subject><subject>Papillomavirus Vaccines</subject><subject>Patient Acceptance of Health Care - statistics &amp; numerical data</subject><subject>Prevention</subject><subject>Research Letter</subject><subject>United States</subject><subject>Vaccination</subject><subject>Vaccination - statistics &amp; numerical data</subject><subject>Vaccination - trends</subject><subject>Vaccines</subject><subject>Warts</subject><subject>Young Adult</subject><subject>Young adults</subject><issn>0098-7484</issn><issn>1538-3598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkc9LwzAUx4Mobk6vHjxIwYsHW19-dEkuwhjqhIGCbuApZG26dbSNNq3gf2_KfqDmkBy-n_d97-WL0DmGCAPg27UudUSA4Ag4iQ9QH8dUhDSW4hD1AaQIOROsh06cW4M_mPJj1KNUAhNc9NHN5GUezHWS5JVuclsFo9JWy-Ddtv4epW3RuCCvgmZlgtnrKTrKdOHM2fYdoNnD_dt4Ek6fH5_Go2moY6BNyIYyFQsGnOkM48xwzRg2CxIz0GBkpoc6TYfGJPGCp1oMkwyw5IQI8AyJMR2gu43vR7soTZqYqql1oT7qvNT1t7I6V3-VKl-ppf1SAgQQwr3B9dagtp-tcY0qc5eYotCVsa1TvomQgnJgHr36h65tW1d-PU9RTJnEcWcYbaikts7VJtsPg0F1QaguCNUFobogfMHl7xX2-O7nPXCxAbq6nUo4lwQk_QEvv4qr</recordid><startdate>20210427</startdate><enddate>20210427</enddate><creator>Chen, Michelle M</creator><creator>Mott, Nicole</creator><creator>Clark, Sarah J</creator><creator>Harper, Diane M</creator><creator>Shuman, Andrew G</creator><creator>Prince, Mark E. P</creator><creator>Dossett, Lesly A</creator><general>American Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7TK</scope><scope>7TS</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210427</creationdate><title>HPV Vaccination Among Young Adults in the US</title><author>Chen, Michelle M ; Mott, Nicole ; Clark, Sarah J ; Harper, Diane M ; Shuman, Andrew G ; Prince, Mark E. P ; Dossett, Lesly A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a503t-469d8b4074af11fe7a441eb2540a0e9fa6add6eec5b7da86cf01972280b252513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adolescent</topic><topic>Age</topic><topic>Anogenital</topic><topic>Cancer</topic><topic>Female</topic><topic>Human papillomavirus</topic><topic>Humans</topic><topic>Immunization</topic><topic>Letter</topic><topic>Letters</topic><topic>Male</topic><topic>Males</topic><topic>Oropharyngeal cancer</topic><topic>Papillomavirus Infections - prevention &amp; control</topic><topic>Papillomavirus Vaccines</topic><topic>Patient Acceptance of Health Care - statistics &amp; numerical data</topic><topic>Prevention</topic><topic>Research Letter</topic><topic>United States</topic><topic>Vaccination</topic><topic>Vaccination - statistics &amp; numerical data</topic><topic>Vaccination - trends</topic><topic>Vaccines</topic><topic>Warts</topic><topic>Young Adult</topic><topic>Young adults</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Michelle M</creatorcontrib><creatorcontrib>Mott, Nicole</creatorcontrib><creatorcontrib>Clark, Sarah J</creatorcontrib><creatorcontrib>Harper, Diane M</creatorcontrib><creatorcontrib>Shuman, Andrew G</creatorcontrib><creatorcontrib>Prince, Mark E. P</creatorcontrib><creatorcontrib>Dossett, Lesly A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>JAMA : the journal of the American Medical Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Michelle M</au><au>Mott, Nicole</au><au>Clark, Sarah J</au><au>Harper, Diane M</au><au>Shuman, Andrew G</au><au>Prince, Mark E. P</au><au>Dossett, Lesly A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HPV Vaccination Among Young Adults in the US</atitle><jtitle>JAMA : the journal of the American Medical Association</jtitle><addtitle>JAMA</addtitle><date>2021-04-27</date><risdate>2021</risdate><volume>325</volume><issue>16</issue><spage>1673</spage><epage>1674</epage><pages>1673-1674</pages><issn>0098-7484</issn><eissn>1538-3598</eissn><abstract>The human papillomavirus (HPV) vaccine was approved for females in 2006 and males in 2009 for the prevention of anogenital cancer and warts. The indications were expanded in 2020 to include the prevention of oropharyngeal cancer, which is more common in males. The Advisory Committee on Immunization Practices recommends routine vaccination with 2 doses at age 11 to 12 years, with catch-up vaccination at age 13 to 26 years (limited to age 13-21 years from 2011 to 2019 for males).2 If the first dose occurs after age 15 years, a 3-dose series is recommended.</abstract><cop>United States</cop><pub>American Medical Association</pub><pmid>33904878</pmid><doi>10.1001/jama.2021.0725</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0098-7484
ispartof JAMA : the journal of the American Medical Association, 2021-04, Vol.325 (16), p.1673-1674
issn 0098-7484
1538-3598
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8080227
source MEDLINE; American Medical Association Journals
subjects Adolescent
Age
Anogenital
Cancer
Female
Human papillomavirus
Humans
Immunization
Letter
Letters
Male
Males
Oropharyngeal cancer
Papillomavirus Infections - prevention & control
Papillomavirus Vaccines
Patient Acceptance of Health Care - statistics & numerical data
Prevention
Research Letter
United States
Vaccination
Vaccination - statistics & numerical data
Vaccination - trends
Vaccines
Warts
Young Adult
Young adults
title HPV Vaccination Among Young Adults in the US
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T19%3A40%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HPV%20Vaccination%20Among%20Young%20Adults%20in%20the%20US&rft.jtitle=JAMA%20:%20the%20journal%20of%20the%20American%20Medical%20Association&rft.au=Chen,%20Michelle%20M&rft.date=2021-04-27&rft.volume=325&rft.issue=16&rft.spage=1673&rft.epage=1674&rft.pages=1673-1674&rft.issn=0098-7484&rft.eissn=1538-3598&rft_id=info:doi/10.1001/jama.2021.0725&rft_dat=%3Cproquest_pubme%3E2531349157%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2531349157&rft_id=info:pmid/33904878&rft_ama_id=2779209&rfr_iscdi=true